Is Mirion Technologies (MIR) overvalued or fairly valued?

MarketChacha shows Mirion Technologies's valuation in context — a trailing P/E of about 254.0, a forward P/E of about 22.6, a price-to-book of about 2.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Mirion Technologies's revenue?

Mirion Technologies reported revenue of $925.4M for FY2025, with net profit of $28.8M, per official filings.

What is the share price of Mirion Technologies (MIR)?

Mirion Technologies last traded at $15.24 (+2.1% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

Mirion Technologies

MIR · NYSE · Technology · United States

Snapshot

TickerMIR

ExchangeNYSE

SectorTechnology

IndustrySpecialty Industrial Machinery

CountryUnited States

Employees3,200

HeadquartersAtlanta, United States

Websitewww.mirion.com

Filings tracked19

About Mirion Technologies

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Who owns it

Insiders3.4%
Institutions96.6%
Public & other0.0%

475 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.15.73%
Vanguard Portfolio Management LLC7.47%
T. Rowe Price Investment Management, Inc.5.87%
Vanguard Capital Management LLC4.36%
Goldman Sachs Group Inc4.28%
State Street Corporation4.08%
Alyeska Investment Group, L.p.3.92%
Cooperman, Leon G.3.45%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Latest ROE of 1.5% is on the low side — the business earns a modest return on shareholder capital.

Net margin trend-12.1% → 3.1%

Margin has expanded by about 15.2 points — the business is getting more profitable.

Return on equity1.5%

Latest ROE of 1.5% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $340.1M · EPS 0.21

Est. earnings growth +39.6%

Next fiscal year

Rev $1.2B · EPS 0.67

Est. earnings growth +23.5%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$925.4M

Net margin

3.1%

ROE

1.5%

Revenue CAGR (2y)

+7.5%

EPS (FY2025)

0.11

Net profit (FY2025)

$28.8M

Ask MarketChacha about MIR

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$925.4M	$28.8M	0.11	3.1%	1.5%
FY2024	$860.8M	$-36.1M	-0.18	-4.2%	-2.4%
FY2023	$800.9M	$-96.9M	-0.49	-12.1%	-6.5%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$266.8M	$7.7M	0.03	2.9%
2026Q1	$257.6M	$-3.4M	-0.01	-1.3%
2025Q3	$223.1M	$2.9M	0.01	1.3%
2025Q2	$222.9M	$8.3M	0.03	3.7%
2025Q1	$202.0M	$300,000	0.00	0.1%
2024Q3	$206.8M	$-13.6M	-0.07	-6.6%
2024Q2	$207.1M	$-11.7M	-0.06	-5.6%
2024Q1	$192.6M	$-25.8M	-0.13	-13.4%
2023Q3	$191.2M	$-12.1M	-0.06	-6.3%
2023Q2	$197.2M	$-27.7M	-0.14	-14.0%
2023Q1	$182.1M	$-41.9M	-0.22	-23.0%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Other events, Exhibits
SEC8/31/2026material
10-Q filing
SEC7/29/2026
8-K — Results of operations, Exhibits
SEC7/28/2026material
8-K — Executive/director change, Exhibits
SEC7/2/2026material
8-K — Shareholder vote results, Exhibits
SEC5/14/2026material
10-Q filing
SEC4/29/2026
8-K — Results of operations, Exhibits
SEC4/28/2026material
8-K — Executive/director change, Exhibits
SEC4/13/2026material
10-K filing
SEC2/19/2026
8-K — Results of operations, Exhibits
SEC2/10/2026material

2025

8-K — Material agreement, Material financial obligation, Exhibits
SEC12/8/2025material
8-K — Other events, Exhibits
SEC12/1/2025material
8-K — Other events, Exhibits
SEC11/7/2025material
10-Q filing
SEC10/29/2025
8-K — Results of operations, Exhibits
SEC10/28/2025material
8-K — Material agreement, Material financial obligation, Unregistered equity sale, Other events, Exhibits
SEC9/30/2025material
8-K — Other events, Exhibits
SEC9/24/2025material
10-Q filing
SEC8/1/2025
8-K — Results of operations, Exhibits
SEC7/31/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.